Cargando…

Highly sensitive molecular diagnosis of prostate cancer using surplus material washed off from biopsy needles

INTRODUCTION: Currently, final diagnosis of prostate cancer (PCa) is based on histopathological analysis of needle biopsies, but this process often bears uncertainties due to small sample size, tumour focality and pathologist's subjective assessment. METHODS: Prostate cancer diagnostic signatur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bermudo, R, Abia, D, Mozos, A, García-Cruz, E, Alcaraz, A, Ortiz, Á R, Thomson, T M, Fernández, P L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242534/ https://www.ncbi.nlm.nih.gov/pubmed/22009027 http://dx.doi.org/10.1038/bjc.2011.435

Ejemplares similares

Construction of tissue microarrays from prostate needle biopsy specimens
por: Jhavar, S, et al.
Publicado: (2005)

Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer
por: Nonomura, N, et al.
Publicado: (2007)

Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology
por: Carpi, A, et al.
Publicado: (2006)

Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital
por: Loubeyre, P, et al.
Publicado: (2009)

Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma
por: Lieske, B, et al.
Publicado: (2006)

A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
por: Bediaga, N G, et al.
Publicado: (2013)

DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
por: Paziewska, A, et al.
Publicado: (2014)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours
por: Karger, S, et al.
Publicado: (2012)

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
por: Shipitsin, M, et al.
Publicado: (2014)

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues
por: Riddick, A C P, et al.
Publicado: (2005)

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer
por: Ali, S, et al.
Publicado: (2012)

KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?
por: Saridaki, Z, et al.
Publicado: (2015)

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
por: Knight, J F, et al.
Publicado: (2008)

Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies
por: Castells, X, et al.
Publicado: (2012)

Asporin is a stromally expressed marker associated with prostate cancer progression
por: Rochette, Annie, et al.
Publicado: (2017)

DKC1 overexpression associated with prostate cancer progression
por: Sieron, P, et al.
Publicado: (2009)

Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples
por: Collet, J F, et al.
Publicado: (2005)

Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate
por: Elkahwaji, J E, et al.
Publicado: (2009)

ERK5 signalling in prostate cancer promotes an invasive phenotype
por: Ramsay, A K, et al.
Publicado: (2011)

Melanoma sentinel node biopsy and prediction models for relapse and overall survival
por: Mitra, A, et al.
Publicado: (2010)

Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells
por: McPherson, R A C, et al.
Publicado: (2009)

Prognostic relevance of Tiam1 protein expression in prostate carcinomas
por: Engers, R, et al.
Publicado: (2006)

Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer
por: Ivil, K D, et al.
Publicado: (2006)

Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion
por: Lambert, L A, et al.
Publicado: (2008)

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
por: Hol, L, et al.
Publicado: (2009)

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)

Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer
por: Mukherjee, R, et al.
Publicado: (2011)

Investigating prostate cancer tumour–stroma interactions: clinical and biological insights from an evolutionary game
por: Basanta, D, et al.
Publicado: (2012)

Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer
por: Wilson, C, et al.
Publicado: (2008)

A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasis
por: Bijnsdorp, I V, et al.
Publicado: (2012)

Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
por: Yates, C C, et al.
Publicado: (2007)

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
por: Yoshimoto, M, et al.
Publicado: (2007)

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
por: Landers, K A, et al.
Publicado: (2008)

Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV
por: de Micco, C, et al.
Publicado: (2008)

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
por: Willis, Sarah R, et al.
Publicado: (2014)

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer
por: Gowardhan, B, et al.
Publicado: (2005)

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study
por: Lessard, L, et al.
Publicado: (2005)

Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3)
por: Houssami, N, et al.
Publicado: (2007)

Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r7fm39afacfgfoqhbeh4einvdi